GO, Yun Young,고윤영,KIM, Mee Hyein,김미현,SHIN, Jin Soo,신진수,KU, Keunbon,구근본,LEE, Ge Hyeong,이계형,LIM, Hee-Jong,임희종,LEE, Sang Ho,이상호
申请号：
KRKR2018/002762
公开号：
WO2018/174442A1
申请日:
2018.03.08
申请国别(地区):
WO
年份:
2018
代理人:
摘要：
The present invention relates to a compound for treating diseases caused by a coronavirus infection. The compound exhibits excellent inhibitory activity against coronaviruses, and is useful as a pharmaceutical composition for preventing or treating coronavirus-induced diseases, such as Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome (SARS), etc.La présente invention concerne un composé pour le traitement des maladies provoquées par une infection à coronavirus. Le composé présente une excellente activité inhibitrice contre les coronavirus, et est utile sous forme de composition pharmaceutique pour la prévention ou le traitement des maladies induites par un coronavirus, tel que le coronavirus du syndrome respiratoire du Moyen-Orient (MERS-CoV), le syndrome respiratoire aigu sévère (SRAS) , etc.코로나 바이러스 감염으로 인한 질환 치료용 화합물에 관한 것으로, 상기 화합물은 코로나 바이러스에 대해 우수한 억제 활성을 나타내어, 코로나 바이러스로 인해 유발되는 메르스, 사스 등 질환의 예방 또는 치료용 약학적 조성물로 유용하다.
